353 related articles for article (PubMed ID: 23257360)
1. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.
Subramanian M; Thorp E; Hansson GK; Tabas I
J Clin Invest; 2013 Jan; 123(1):179-88. PubMed ID: 23257360
[TBL] [Abstract][Full Text] [Related]
2. Impaired Autophagy in CD11b
Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosis.
Frodermann V; van Puijvelde GH; Wierts L; Lagraauw HM; Foks AC; van Santbrink PJ; Bot I; Kuiper J; de Jager SC
J Immunol; 2015 Mar; 194(5):2208-18. PubMed ID: 25653425
[TBL] [Abstract][Full Text] [Related]
4. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.
Bosschaerts T; Guilliams M; Stijlemans B; Morias Y; Engel D; Tacke F; Hérin M; De Baetselier P; Beschin A
PLoS Pathog; 2010 Aug; 6(8):e1001045. PubMed ID: 20714353
[TBL] [Abstract][Full Text] [Related]
5. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.
Naiki Y; Sorrentino R; Wong MH; Michelsen KS; Shimada K; Chen S; Yilmaz A; Slepenkin A; Schröder NW; Crother TR; Bulut Y; Doherty TM; Bradley M; Shaposhnik Z; Peterson EM; Tontonoz P; Shah PK; Arditi M
J Immunol; 2008 Nov; 181(10):7176-85. PubMed ID: 18981139
[TBL] [Abstract][Full Text] [Related]
6. Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity.
Szczepanik M; Majewska-Szczepanik M; Wong FS; Kowalczyk P; Pasare C; Wen L
Contact Dermatitis; 2018 Oct; 79(4):197-207. PubMed ID: 29943459
[TBL] [Abstract][Full Text] [Related]
7. Myd88 is required for an antibody response to retroviral infection.
Browne EP; Littman DR
PLoS Pathog; 2009 Feb; 5(2):e1000298. PubMed ID: 19214214
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
10. MyD88 and interferon-alpha/beta are differentially required for dendritic cell maturation but dispensable for development of protective memory against Listeria.
Tam MA; Wick MJ
Immunology; 2009 Nov; 128(3):429-38. PubMed ID: 20067542
[TBL] [Abstract][Full Text] [Related]
11. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.
Teichmann LL; Schenten D; Medzhitov R; Kashgarian M; Shlomchik MJ
Immunity; 2013 Mar; 38(3):528-40. PubMed ID: 23499488
[TBL] [Abstract][Full Text] [Related]
12. The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering.
Singh-Jasuja H; Thiolat A; Ribon M; Boissier MC; Bessis N; Rammensee HG; Decker P
Immunobiology; 2013 Jan; 218(1):28-39. PubMed ID: 22445076
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell specific targeting of MyD88 signalling pathways in vivo.
Arnold-Schrauf C; Berod L; Sparwasser T
Eur J Immunol; 2015 Jan; 45(1):32-9. PubMed ID: 25403892
[TBL] [Abstract][Full Text] [Related]
14. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation.
Lamagna C; Scapini P; van Ziffle JA; DeFranco AL; Lowell CA
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3311-20. PubMed ID: 23940344
[TBL] [Abstract][Full Text] [Related]
15. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.
Weber C; Meiler S; Döring Y; Koch M; Drechsler M; Megens RT; Rowinska Z; Bidzhekov K; Fecher C; Ribechini E; van Zandvoort MA; Binder CJ; Jelinek I; Hristov M; Boon L; Jung S; Korn T; Lutz MB; Förster I; Zenke M; Hieronymus T; Junt T; Zernecke A
J Clin Invest; 2011 Jul; 121(7):2898-910. PubMed ID: 21633167
[TBL] [Abstract][Full Text] [Related]
16. The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway.
Ye Z; Zhong L; Zhu S; Wang Y; Zheng J; Wang S; Zhang J; Huang R
Cell Death Dis; 2019 Jul; 10(7):507. PubMed ID: 31263109
[TBL] [Abstract][Full Text] [Related]
17. MyD88 and IFN-alphabeta differentially control maturation of bystander but not Salmonella-associated dendritic cells or CD11cintCD11b+ cells during infection.
Tam MA; Sundquist M; Wick MJ
Cell Microbiol; 2008 Jul; 10(7):1517-29. PubMed ID: 18363877
[TBL] [Abstract][Full Text] [Related]
18. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.
Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F
J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314
[TBL] [Abstract][Full Text] [Related]
19. Critical role of TRIF and MyD88 in Mycobacterium tuberculosis Hsp70-mediated activation of dendritic cells.
Kim TH; Shin SJ; Park YM; Jung ID; Ryu SW; Kim DJ; Park JH; Park JH
Cytokine; 2015 Feb; 71(2):139-44. PubMed ID: 25461391
[TBL] [Abstract][Full Text] [Related]
20. Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.
Lievens D; Habets KL; Robertson AK; Laouar Y; Winkels H; Rademakers T; Beckers L; Wijnands E; Boon L; Mosaheb M; Ait-Oufella H; Mallat Z; Flavell RA; Rudling M; Binder CJ; Gerdes N; Biessen EA; Weber C; Daemen MJ; Kuiper J; Lutgens E
Eur Heart J; 2013 Dec; 34(48):3717-27. PubMed ID: 22613345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
